Johnson & Johnson has agreed to settle Texas’ lawsuit for the company’s fraudulent marketing of Risperdal. The is the first time J&J has settled a state’s claim for this reason. The settlement comes less than a month after J&J’s $1 billion settlement with the U.S. government.
Read more Discuss →
Mad in America hosts blogs by a diverse group of writers. These posts are designed to serve as a public forum for a discussion—broadly speaking—of psychiatry and its treatments. The opinions expressed are the writers’ own.
Mad in America has made some changes to the commenting process. You no longer need to login or create an account on our site to comment. The only information needed is your name, email and comment text. Comments made with an account prior to this change will remain visible on the site.